Open AccessSelection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer
Author(s) -
Ingmar Königsrainer
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i37.4153
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , peritoneal carcinomatosis , cancer , chemotherapy , intraperitoneal chemotherapy , selection (genetic algorithm) , oncology , surgery , intensive care medicine , ovarian cancer , artificial intelligence , computer science , colorectal cancer
Peritoneal carcinomatosis in gastric cancer is associated with a dismal prognosis. Systemic chemotherapy is not effective because of the existence of a blood-peritoneal barrier. Cytoreductive surgery and intraperitoneal chemotherapy can improve survival and quality of life in selected patients. Patient selection for this multimodal approach is one of the most critical issues, and calls for interdisciplinary evaluation by radiologists, medical and surgical oncologists, and anaesthetists. This article sets forth criteria for selection of gastric cancer patients suffering from peritoneal carcinomatosis.